| Company Name: |
Biolab Reagents |
| Tel: |
027-65279366 18108604356 |
| Email: |
products@biolabreagent.com |
|
| | Research Grade Semzuvolimab (DHB95908) Basic information |
| | Research Grade Semzuvolimab (DHB95908) Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Research Grade Semzuvolimab (DHB95908) Usage And Synthesis |
| Uses | Semzuvolimab is a human IgG1κ antibody, targeting to p55, T cell surface antigen T4/Leu-3 (CD4). Human CD4 antibodies can neutralize HIV infection and have the potential to inhibit HAART stable HIV infection[1][2]. | | References | [1] Wang Changyi, et al. Treatment and sustained virologic remission of HIV infection by antibodies to CD4 in HAART stabilized patients. World Intellectual Property Organization, WO2018035001 A1. 2018-02-22. [2] Semzuvolimab. IMGT/mAb-DB. |
| | Research Grade Semzuvolimab (DHB95908) Preparation Products And Raw materials |
|